INTRODUCTION
Ciprofloxacin (CPX) is a fluorinated quinolone antibacterial which is chemically 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid (The Merck Index, 2006) . Ciprofloxacin is a broad spectrum antibiotic active against both Gram-positive and Gram-negative bacteria. It functions by inhibiting DNA gyrase, a type II topoisomerase, and topoisomerase IV enzymes necessary to separate bacterial DNA, thereby inhibiting cell division (Drlica and Zhao, 1997) . Tinidazole (TNZ) is chemically 1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole (The Merck Index, 2006) . It is active against both protozoa and obligate anaerobic bacteria. It damages DNA strands or inhibit DNA synthesis in microorganism.
Literature survey revealed that various analytical methods such as UV spectroscopy (Bombale et al., 1997; Sharma et al., 2011) , HPLC (Bhatia et al., 1999) , pulsepolarography (Salvi and Sathe, 2010) have been reported for the simultaneous estimation of both the drugs. This study is useful because these two drugs are commonly administered simultaneously. The UV spectrophotometric analysis is often preferred in quality control testing and ordinary laboratories due to its broader availability, suitability and ease of use (Nijhu et al., 2011) . The aim of the present investigation is to develop a simple, sensitive and reproducible UV Spectrophotometric method for analysis of CPX and TNZ in a combined tablet dosage form and hence an economical method was developed and validated according to the ICH guidelines.
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MATERIALS AND METHODS
Instruments
Absorbance measurements were made on Shimadzu 1800 UV/Visible spectrophotometer with a pair of 10 mm matched quartz cells, Shimadzu digital balance for weighing and Cintex sonicatorwere used.
Chemicals and reagents
All chemicals were of analytical reagent grade and solutions were prepared with double distilled water. Ciprofloxacin and Tinidazole gift samples were obtained from Dr. Reddy's Laboratories, Hyderabad. Potassium dihydrogen ortho phosphate and Methanol were procured from E. Merck Co., Mumbai, India. Sodium hydroxide was purchased from Qualigen's. Combined tablets of CPX and TNZ (Ciplox-Tz, Ciprolet) were procured from the local pharmacy.
Procedure
Preparation of phosphate buffer (pH 6.8)
Accurately weigh about 0.896 gm of NaOH, 6.804 gm of KH₂PO₄, dissolve in distilled water and make up the volume to 1Litre with distilled water.
Preparation of stock solution (1000µg/mL)
Accurately weighed quantity of pure Ciprofloxacin (10mg) and pure Tinidazole (10mg) were transferred into two separate10mL volumetric flasks, dissolved in methanol and made up the volume to 10mL with the same solvent. The stock solution was sonicated for 2min.
Preparation of working standard solution (100µg/mL)
From the above stock solution 1mL each of CPX and TNZ was taken,transferred to separate 10mL volumetric flasks and the volume was made up to 10 mL with phosphate buffer.
Simultaneous Equations Method (Method A)
10μg/mL solutions of CPX and TNZ were prepared separately in phosphate buffer (pH 6.8) and the solutions were scanned against blank in the entire UV range to determine the λmax values. Clear peaks were observed at 271nm for CPX and 318nm for TNZ. Hence these wavelengths were chosen as the λmax values for each drug respectively (Fig  1) .Standard solutions of CPX and TNZ in the concentration range of 10-35µg/mL and 10-80µg/mL respectively were prepared in phosphate buffer and the absorbance of these solutions was measured at 271nm and 318 nm. Calibration curves were plotted to verify the Beer's law and the absorptivity values calculated at the respective wavelengths for both the drugs. Two simultaneous equations as below were formed using these absorptivity values, A (1%, 1cm). A 1 = 924bC x + 108bC y A 2 = 339bC x + 367bC y Where, CX and CY are the concentrations of CPX and TNZ measured in gm/100mLin sample solutions. A1 and A2 are the absorbances of mixture at selected wavelengths 271nm and 318nm respectively.
Absorbance Ratio Method/ Q-Analysis (Method B)
The absorbance ratio method is a modification of the simultaneous equation procedure. It depends on the property that for a substance, which obeys Beer's law at all wavelength, the ratio of absorbance at any two wavelengths is constant value independent of concentration or path length. E.g. two dilutions of the same substance give the same absorbance ratio A1 / A2. In the USP, this ratio is referred to as Q value. In the quantitative assay of two components in admixture by the absorbance ratio method, absorbances are measured at two wavelengths, one being the λ max of one of the components (λ2) and the other being a wavelength of equal absorptivity of the two components (λ1), i.e., an iso-absorptive point (Beckett and Stenlake, 2005) . A series of standard solutions of CPX and TNZ in the concentration range of 10-35µg/mL and 10-80µg/mL respectively were prepared in phosphate buffer and the absorbance of these solutions was measured at 292nm (iso-absorptive point) and 271 nm(λmax of CPX) (Figure 1 ). Calibration The concentration of two drugs in mixture was calculated by using the following equations:
Where, A1 and A2 are the absorbances of mixture at 292nm and 271nm,ax1 (107.8), ax2 (367.3) and ay1 (924.6), ay2 (348.6) are A (1%, 1 cm) of TNZ and CPX at 292nm and 271nm respectively, Q m = A 2 A 1 ,Q x = ax 2 ax 1 and Q y = ay 2 ay 1 Assay of tablets by Method A and B 20 commercial tablets of CPX and TNZ were triturated and powder equivalent to 10mg of TNZ and 8.0mg of CPX respectively was weighed and transferred to 10mL volumetric flask, dissolved in methanol, volume adjusted up to the mark with the same solvent and mixed well with the help of a sonicator. The solution was filtered through Whatman filter paper no 40.1mL of the above filtrate was diluted to 10mL with phosphate buffer to obtain a 100µg/mL solution with respect to TNZ. From this solution an aliquot was taken and made up the volume to 10mL with phosphate buffer expected to contain 10 and 8µg/mL of CPX and TNZ respectively. The absorbance of the sample solution was measured at 271nm and 318nm(Method A), 292nm and 271nm (Method B) and the data analyzed accordingly using the necessary equations. The analysis procedure was repeated for 6 times with tablet formulations. The result of analysis of tablet formulation is reported in Table 2 .
Validation (Method A&B) Linearity Appropriate dilutions of working standard solutions for CPX and TNZ were prepared in the concentration range of 10-35µg/mL and 10-80µg/mL, respectively and analyzed as per the developed methods A & B.
The results are reported in Table 3 .
Accuracy and Recovery studies
To check the accuracy of the proposed method, recovery studies were carried out by standard addition method at three different levels according to ICH guidelines. A series of solutions of CPX and TNZ at 80%, 100%, and 120% of the standard preparation in the ratio of the formulation were prepared and checked for accuracy by determining the absorbance values at λmax of 271nm and 318nm (Method A) 292nm and 271nm (method B) respectively. To a fixed concentration of the formulation, varying concentrations of pure drug solutions were added and percentage recoveries calculated. The result of the analysis is given in Table 4 .
Precision
Precision studies were performed at three different concentrations in the ratio of the formulation, each concentration prepared three times for CPX and TNZ together. The result of the analysis is given in Table 5 .
RESULTS AND DISCUSSION
Ciprofloxacin and Tinidazole exhibited maximum absorption at 271nm and 318nm (Method A) ,they were also analyzed at 292nm and 271nm (Method B). CPX obeyed Beer's law in the concentration range of 10-35μg/mL while TNZ obeyed the Beer's law in the concentration range of 10-80μg/mL (Method A & B). The precision data shows that the reproducibility of the assay procedure was satisfactory. The recovery studies done by standard addition method has given satisfactory results with an average percentage recovery of 98.6% and 98.7% (Method A), 98.4% and 99.0% (Method B) for CPX and TNZ respectively. The regression analysis of the calibration curves and the optical characteristics 
such as Beer's law limits, molar absorptivities and Sandell's sensitivities were also determined. The results shown in Table 3 .
CONCLUSION
Two new, simple, sensitive and economical UV spectrophotometric methods were developed for the simultaneous analysis of Ciprofloxacin and Tinidazole in bulk and in pharmaceutical formulations. The developed methods were validated and from the statistical data, it was found that the methods were linear, accurate and precise and can be successfully applied for the analysis of pharmaceutical formulations without interference of excipients.
